Back
Emergent BioSolutions Stock Price Chart
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
53
EBS
Emergent BioSolutions
Last Price:
$5.88
Seasonality Move:
16.4%
7 Day Trial
ALL ACCESS PASS
$
7
FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EBS is experiencing slight buying pressure.
Emergent BioSolutions Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.3 | Buy |
| 20-day SMA: | 5.11 | Buy |
| 50-day SMA: | 5.28 | Buy |
| 200-day SMA: | 8.26 | Sell |
| 8-day EMA: | 5.47 | Buy |
| 20-day EMA: | 5.09 | Buy |
| 50-day EMA: | 3.92 | Buy |
| 200-day EMA: | 1.56 | Buy |
Emergent BioSolutions Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.48 | Buy |
| Relative Strength Index (14 RSI): | 57.12 | Buy |
| Chaikin Money Flow: | 34281 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.45 - 5.49) | Buy |
| Bollinger Bands (100): | (5.06 - 9.7) | Sell |
Emergent BioSolutions Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Emergent BioSolutions Stock
Is Emergent BioSolutions Stock a Buy?
-
Emergent BioSolutions share price is 5.84 while EBS 8-day simple moving average is 5.30, which is a Buy signal.
-
The stock price of EBS is 5.84 while Emergent BioSolutions 20-day SMA is 5.11, which makes it a Buy.
-
Emergent BioSolutions 50-day simple moving average is 5.28 while EBS share price is 5.84, making it a Buy technically.
-
EBS stock price is 5.84 and Emergent BioSolutions 200-day simple moving average is 8.26, creating a Sell signal.
EBS Technical Analysis vs Fundamental Analysis
Buy
53
Emergent BioSolutions (EBS)
is a Buy
Is Emergent BioSolutions a Buy or a Sell?
-
Emergent BioSolutions stock is rated a BuyThe current Emergent BioSolutions [EBS] share price is $5.84. The Score for EBS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Emergent BioSolutions Stock Info
Market Cap:
317M
Price in USD:
5.84
Share Volume:
1.4M
Emergent BioSolutions 52-Week Range
52-Week High:
15.10
52-Week Low:
4.02
Buy
53
Emergent BioSolutions (EBS)
is a Buy
Emergent BioSolutions Share Price Forecast
-
What is the Emergent BioSolutions stock price today?The Emergent BioSolutions stock price is 5.84 USD today.
-
Will EBS stock go up or go down?Emergent BioSolutions> share price is forecast to RISE/FALL based on technical indicators
-
Is Emergent BioSolutions overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Emergent BioSolutions is not overvalued.
Is Emergent BioSolutions Stock a Buy?
-
Emergent BioSolutions share price is 5.84 while EBS 8-day exponential moving average is 5.47, which is a Buy signal.
-
The stock price of EBS is 5.84 while Emergent BioSolutions 20-day EMA is 5.09, which makes it a Buy.
-
Emergent BioSolutions 50-day exponential moving average is 3.92 while EBS share price is 5.84, making it a Buy technically.
-
EBS stock price is 5.84 and Emergent BioSolutions 200-day simple moving average is 1.56, creating a Buy signal.
Fundamental Analysis of Emergent BioSolutions
Is Emergent BioSolutions a good investment?
-
Analysts estimate an earnings increase this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.53 per share, and a decrease next year of $2.03 per share.
Technical Analysis of Emergent BioSolutions
Should I short Emergent BioSolutions stock?
-
EBS Moving Average Covergence Divergence (MACD) indicator is 0.48, suggesting Emergent BioSolutions is a Buy
-
Emergent BioSolutions Relative Strength Index (RSI) is 57.12, which suggest Emergent BioSolutions is overbought
-
The Bollinger Bands (25) for Emergent BioSolutions is (4.45 - 5.49), which suggest Emergent BioSolutions is a Sell
-
The Bollinger Bands (100) for Emergent BioSolutions is (5.06 - 9.7), which suggest Emergent BioSolutions is a Sell
* Emergent BioSolutions stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.